Aimco Pesticides LtdQ1 FY25Fertilizers & Agrochemicals

Aimco Pesticides Ltd

Q1 FY25 Earnings Call Analysis

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

N/A

Order

N/A

Capex

Yes

1 of 3 growth signals are positive — mixed outlook.

Revenue guidance

Category 3

→FY26 revenue target: Approximately ₹225 crore, reflecting a cautious growth approach.
→Aimco expects to remain profitable in FY26, focusing on positive EBITDA rather than aggressive topline growth.
→Brand sale formulation business targeted for 20% year-on-year growth.
→Increased production capacity and tie-ups enhance formulation brand sales capacity.
→New molecules launched and under registration to drive next-year volume growth, especially in technical manufacturing.
→Volume growth observed in active ingredients (~25%), but value growth constrained due to price declines.
→Expansion plans include new markets (e.g., Brazil, Australia, Indonesia, US) and new product additions.
→Existing bulk formulation sales rising (from 9% in 2023 to 24% in 2025), but company aims to limit bulk sales focus in favor of brand sale profitability.
→Inventory levels being optimized to improve operational efficiency.

Category 3

→Aimco Pesticides targets a cautious 10% revenue growth for FY26, aiming for a top line around ₹225 crore.
→The primary focus for FY26 is to achieve profitability and avoid negative EBITDA after two challenging years.
→Gross margins are expected to remain modest; no significant margin expansion anticipated in the near term.
→Brand sale formulation business is seen as a key growth driver, targeting 20% growth with gross margins around 30-35%.
→New molecules started manufacturing provide potential for volume growth and improved profitability from FY26 onwards.
→Bulk formulation business growth is opportunistic but limited to maintain focus on profitability.
→The company is working on cost reduction and operational efficiencies to improve margins.
→EPS improvement aligned with achieving positive net profits; however, PAT might remain negative in the near term but aims at profitability by FY26.

Get access to all 5 sections — revenue, margin, fundraise, orderbook, and capex — for Aimco Pesticides Ltd and 1,400+ other companies.

→The transcript does not mention any current or future fundraising plans through debt or equity.
→However, it is noted that promoters have infused additional capital into the company through a preferential issue of 2 lakh shares to support operations and growth initiatives.
→No specific details about any new debt or equity fundraising programs, timelines, or amounts are provided.
→The focus remains on cost reduction, margin improvement, and cautious growth without mentioning external fund raising plans.

→The company is actively pursuing bulk formulation business opportunities, especially with a new molecule started last year that has good potential for B2B and brand sales.
→Current volumes with UPL are growing, with the plant running at almost full capacity and expectations of even higher volumes this year.
→Discussions are ongoing with UPL for new molecules, though timelines and commercializations are uncertain.
→They have started initial orders and tie-ups in Brazil for products like Bifenthrin formulation and Triclopyr, with expected sales of around 200-300 tons for Triclopyr in Brazil (~₹100 crore value).
→New molecules under registration in various countries and pilot trials are ongoing.
→No specific numeric order book was mentioned, but the company targets ₹225 crore revenue in FY26, focusing on profitable growth rather than aggressive scaling.
→The company is cautious and focused on margin improvement alongside volume growth.

Yes

→Aimco Pesticides has CapEx plans to increase production capacity for two new molecules already started.
→No specific timeline set for the execution of these CapEx plans; implementation will be based on customer negotiations and confirmed business volumes.
→Other planned CapEx includes small investments focused on safety improvements and debottlenecking existing processes.
→Capital infusion has been made by promoters through a preferential issue of 2 lakh shares to support operations and growth.
→The company is cautious about growth to maintain profitability and is closely managing costs and margins amid market challenges.

How does Aimco Pesticides Ltd rank vs peers in Fertilizers & Agrochemicals?

Pro feature

1Aimco Pesticides Ltd

Rev 3Mar 3

See full Fertilizers & Agrochemicals sector rankings

Want more stocks like Aimco Pesticides Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.